Skip to content

A Better Everyday Life Among Persons With Chronic Conditions

A Better Everyday Life - a Complex Intervention Addressing Ability to Perform Activities of Daily Living Among Persons Living With Chronic Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04295837
Acronym
ABLE
Enrollment
78
Registered
2020-03-05
Start date
2019-12-09
Completion date
2021-10-21
Last updated
2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Conditions, Multiple

Brief summary

Background: Persons living with chronic conditions often have decreased ability to perform Activities of Daily Living (ADL) tasks, stressing a need to develop and evaluate intervention programs addressing decreased ADL ability. Guided by the British Medical Research Council's guidance (MRC) on how to develop and evaluate complex interventions, the program A Better everyday LifE (ABLE), a home-based intervention program, was developed and feasibility tested. The current phase concerns a full-scale evaluation of the ABLE program including evaluation of effectiveness, processes and cost-effectiveness. Material and Methods: The design involves a randomized controlled trial, initiated with an internal pilot. The study will include eighty (n=80) home dwelling persons living with chronic conditions, experiencing problems performing ADL. Participants are randomized to either intervention (ABLE) or control (usual care). Co-primary outcomes are self-reported ADL ability measured using ADL-Questionnaire (ADL-Q) and observed ADL motor ability measured using Assessment of Motor and Process Skills (AMPS). Secondary outcomes are perceived satisfaction with ADL task performance measured using ADL-Q; observed ADL process ability measured using AMPS; and Goal Attainment measured using Goal-Attainment-Scaling (GAS). Data is collected at baseline, post intervention and six months after baseline. Process evaluation data are collected using registration forms and semi-structured qualitative interviews. The economic evaluation will be performed from a health care sector perspective with 6 months follow-up. Costs will be estimated based on micro costing and national registries. Effects will be Quality Adjusted Life Years and changes in AMPS ADL ability.

Detailed description

Due to the Covid-19 pandemic, the study was truncated on March 11th 2020. Data collected at this time was assessed to be sufficient to answer most pilot study questions, and it was decided to turn the internal pilot into an external pilot. Based on the results of the external pilot, a few adjustments on outcome measurements, inclusion criteria and extraction of information on usual care were applied, before initiation of the full scale trial. Hence ADL-I replaced ADL-Q as primary outcome measurement. Data collection for full scale trial was initiated August 1st 2020.

Interventions

OTHERABLE

Home-based occupational therapy compensatory programme addressing activities of daily living

OTHERUsual Care

Standard occupational therapy

Sponsors

University of Southern Denmark
CollaboratorOTHER
VIA University College
CollaboratorOTHER
Parker Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ one year since medical diagnosed with one or more chronic conditions * Perceive problems performing ADL tasks * ≥ 18 years of age * Lives in own home * Motivated and ready for making changes in ADL performance * Motivated and ready to participate in program * Communicates independently and relevant * Able to understand and relevantly answer a questionnaire

Exclusion criteria

* PADL problems with acute need for help (if the client does not already receive help from home carer * Known substance abuse * Mental illness, and/or other acute illness effecting ADL task performance * Communication barriers (e.g. severe cognitive deficits; and barriers that prevents receiving information on study)

Design outcomes

Primary

MeasureTime frameDescription
Change in observed ADL motor ability - with the Assessment of Motor and Process Skills (AMPS)Week 10Observation-based measure of ADL ability - motor
Change in self-reported ADL ability - with the ADL-Interview (ADL-I)Week 10Self-report based on interview addressing perceived ability to perform ADL tasks. Linear measures of ADL ability will be generated using Rasch measurement models. Higher scores mean more ADL ability.

Secondary

MeasureTime frameDescription
Change in observed ADL process ability - with the Assessment of Motor and Process skills (AMPS)Week 10Observation-based measure of ADL ability - process
Change in observed ADL motor ability - with the Assessment of Motor and Process skills (AMPS)Week 27Observation-based measure of ADL ability - motor
Change in self-reported satisfaction with ADL ability - with the ADL-Interview (ADL-IS)Week 10Self-report based on interview addressing satisfaction with perceived ability to perform ADL tasks. Linear measures of satisfactions with ADL ability will be generated using Rasch measurement models. Higher scores mean more satisfaction.
Change in self-reported ADL ability - with the ADL-Interview (ADL-I)Week 27Self-report based on interview addressing perceived ability to perform ADL tasks. Linear measures of ADL ability will be generated using Rasch measurement models. Higher scores mean more ADL ability.

Other

MeasureTime frameDescription
EuroQoL 5 dimensions (EQ-5D)Week 10Quality of life
Transition Questionnaire (TRANS-Q)Week 10Perceived change in performance and satisfaction with ADL ability on a Likert scale from much less able/satisfied to fully able/satisfied.
General Health (SF36-SF1)Week 10Perceived general health on 5-point ordinal scale
Client-Weighted-Problems (CWP)Week 10Self-reported weight of identified problems, need for help and hope for the future on an 11-point ordinal scale ranging from '0' representing not at all to '10' representing to a high extent.
Occupational Balance Questionnaire (OBQ11)Week 10Assessing occupational balance

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026